Xilio Therapeutics, Inc. Common Stock (XLO) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for XLO. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 25 institutions reported holding XLO, with 3.4 million shares worth $32.6 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Bain Capital Life Sciences Investors | 664,021 | $6M | UNCHANGED |
| Gilead Sciences | 650,389 | $6M | UNCHANGED |
| Orbimed Advisors | 592,300 | $6M | NEW |
| Frazier Life Sciences Management | 422,505 | $4M | UNCHANGED |
| Stonepine Capital Management | 225,994 | $2M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Xilio Therapeutics, Inc. Common Stock on SentiSense.